Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Only 3 weeks to go until the end of March. If they have anything else up their sleeve we should hear about it soon. I'd imagine that they're close to announcing when the CC will be held as well. Wouldn't be surprised if they scheduled it for early April instead but we'll find out soon either way.
Assuming that the only testing method used to obtain those R33s was the Teng-Man test, would that be reason for concern?
I'm unsure which method is a better predictor of success/accuracy of how our material would work in a device. Can anyone on this board with more technical knowledge speak to this at all?
" After rigorous testing at UCB, we believe our material possesses outstanding electro-optical activity with excellent thermal and chemical stability necessary for producing commercial devices."
Does anyone know if this material testing included Mach-Zender Interferometer testing or just the Teng-man testing??? From what I recall (please correct me if I'm wrong) the testing in Arizona gave different results for Mach-Zender tests than it did for Teng-man which is why Dr Norwood only said that the results were "intriguing". Maybe this is why the newly released test results showed R33 results between 100-125 instead of 250???
I think ours is Frederick J Goetz and not E
Also thought he was younger than 52?
X would know but he's on a fishing trip, right?
I'm surprised that the share price is dropping after we hear that the 'quiet' period is now over and we should expect more updates 'shortly'...
Anyone know why the share price has tanked recently? Short activity? If I had some extra cash right now I'd be buying more...
Great minds (pending the results of LSS testing and the conference call) think alike! ;)
It's interesting that the R33 values of 100-125 are now consistently half of what they initially reported at 250. I wonder why it is that much less now, NOT that it seems to be a problem as it still EXCEEDS what was required by the LSS...Might email them about that just out of curiosity...
Would love to see some insider buying soon! ;)
That's great news, fingers crossed the LSS loves what it sees in their own testing.
My questions for the CC will pertain to this paragraph in the PR:
"These results now allow Lightwave Logic to proceed with plans to develop an advanced telecom modulator. Dr. Fred Leonberger, Senior Advisor to the Company is leading the project. Furthermore, this progress enables the Company to accelerate development of a prototype spatial light modulator it has been working on with Boulder Nonlinear Systems."
When does Lightwave hope to have their own first working prototypes???
It seems clearer now that they were so focused on the LSS that the other projects took a back seat and/or had been delayed due to the thin film coating issues.
Also:
"I would like to thank the Lightwave Logic team along with Dr. Alan Mickelson and everyone at the University of Colorado, Boulder who worked tirelessly on this project."
Hope it pays off very soon!!!!!
I find it surprising that many of you expect a buyout when we still don't have any evidence that Indigo or any other material actually works well inside a device. When/if we get a working device I may start to think that way but not before a demonstration. This is why I want to see a working device so badly. If they were to demonstrate a great device that was cost effective to make I think it would pique the interest of many other companies and would potentially lead to buyout offers much more quickly due to all the attention. As of now we have the attention of one LSS but if Lightwave were demonstrating revolutionary new devices IMO they would be entertaining several LSS.
Do we even know that anyone from Lightwave attended SPIE?
This wait until the end of March is making me incredibly antsy. The last thing I expected for this quarter was for it to be completely quiet and devoid of any news. 4 weeks to go, hope this CC will be worth our while. There's only two things that I want to hear - the LSS liked what they saw and is ready to make deal and/or Lightwave has an amazing and working prototype ready to show that is cost effective and easily reproduced.
So, there's exactly 5 weeks until the last possible day in March for a CC (29th). Anyone think we'll get some news before then or will this just be a quiet period until we receive another "update"?
Also, anyone check the yahoo board lately? Can't believe they are still going at it over there! Gave me a good laugh this morning..
Excellent, thanks! It appears that bavi has a major advantage over Avastin where safety/side effects are concerned.
What is Avastin's safety profile like??? Anyone know if it is comparable to Bavi?
TIA.
That's good to know. I just hope it doesn't take another 10 months until we have any products to demonstrate.
Seeing as the end date for the proposal was 12/31/12 does anyone have any clue if we are still working with Prof. Mickelson on any additional projects?
Agreed BioBS, p values are irrelevant at this point as they will only need to worry about that in the PH III trial. I have been sharing the Peregrine developments with a friend who is a clinical trial manager and she has confirmed that showing statistical significance is only imperative in PH III trials and that the data she has seen in the press releases certainly looks good enough in her opinion to warrant approval of a PH III trial by the FDA.
Don't forget about the 1st line NSCLC results due before the end of June. I wouldn't be surprised if they were ready for release in time for ASCO at the end of May. 3 months is not that far off although it is tough to watch the share price drop after reinforcement of very positive 2nd line NSCLC trial results. Assuming results for the 1st line trial are also extraordinary, if there isn't a partnership inked by the time that data is released then Peregrine should have the upper hand in any negotiations after that point. Despite the way the share price has tanked over the past couple of days, I believe we'll be testing the highs again by the start of summer.
All IMO.
Perdix
361 Chem Chem College of Arts and Sciences Walba, D Perdix Industry I 09/01/2012 08/31/2013 Fast Electro-optic Materials for Tunable Fiber Optic Wavelength Filters $43,952 March
Any chance that Peregrine wants the 1st Line NSCLC results in before they meet with the FDA or that they are necessary before a partner will sign on with them due to the mishap with the 2nd line study???
Maybe the first one? I think Fourier transforms have something to do with Spatial Light Modulation. If so, might be a while longer yet until we see a working prototype.
Boulder Nonlinear Systems
1038 ECE ECE College of Engineering and Applied Science Park, W Boulder Nonlinear Systems Industry I 01/01/2013 06/30/2013 Development of Novel Plasmonic Nanostructure for Achromatic Fourier Transform Lens $50,000 June
1039 ECE ECE College of Engineering and Applied Science McLeod, R Boulder Nonlinear Systems Industry I 09/01/2012 08/31/2014 STTR Phase II: Structural Properties of Carbon Nanotube Polymer Composites $209,000 January
1040 ECE ECE College of Engineering and Applied Science Cogswell, C Boulder Nonlinear Systems Industry I 11/01/2012 10/31/2015 Automation of Quantitative DIC Microscopy for 3D Live-cell Imaging Using Programmable, Active-wave-front Modulation $839,626 March
Good find Buzz. For that kind of cash I'd hope it was a full time project. Would be nice to know what the results were..
We are only 20 minutes into today's trading session. I wouldn't worry too much about the downward trading pressure right now. Headfakes often come early in the first hour after a new PR.
I forgot about the purity. That would certainly make sense for a delay especially when combined with the thin film issues. March seems like it could finally be the start of the "watershed" events for us. At least, here's hoping. I'll be looking for a four leaf clover in the patch around St Patty's day ;)
I can't remember if this has been addressed already but does anyone know why the telecom modulator has been delayed? Was that due to the thin film coating issues that they just recently overcame? I know they mentioned the SLM development as having been affected by those issues but I don't believe we ever heard why the telecom modulator program was delayed.
TIA
Knowing that the NSCLC trial discrepancies only occurred in the 1mg and placebo group, then the data for the 3mg arm should still remain valid, yes???
The data for the 3mg arm was 13.1 months MOS, overall response rate of 17.9%, and Progression free survival of 4.5 months.
Is that data still outstanding compared to current standard of care??? If so, this would still appear to be a promising investment opportunity IMO... Any thoughtful arguments for or against my thought process would be welcome. TIA.
New chromophore dyes huh? Let's hope we aren't back to square one again with purification and characterization.
Must have meant Lightwire which Cisco acquired last year.
With regard to the "random" price spike that we had a few weeks ago, every time this happens my first instinct is to think that Phil Smith is somehow involved and profiting....
More potential competition:
http://phys.org/news/2013-02-patented-technique-key-solar-power.html
A novel fabrication technique developed by UConn engineering professor Brian Willis could provide the breakthrough technology scientists have been looking for to vastly improve today's solar energy systems.
For years, scientists have studied the potential benefits of a new branch of solar energy technology that relies on incredibly small nanosized antenna arrays that are theoretically capable of harvesting more than 70 percent of the sun's electromagnetic radiation and simultaneously converting it into usable electric power. The technology would be a vast improvement over the silicon solar panels in widespread use today. Even the best silicon panels collect only about 20 percent of available solar radiation, and separate mechanisms are needed to convert the stored energy to usable electricity for the commercial power grid. The panels' limited efficiency and expensive development costs have been two of the biggest barriers to the widespread adoption of solar power as a practical replacement for traditional fossil fuels.
Read more at: http://phys.org/news/2013-02-patented-technique-key-solar-power.html#jCp
I'd have to agree F2. I think the only news we may get concerning the LSS is whether or not Lightwave has coated their device yet. Otherwise I'm expecting to hear more about the potential (or, at this point agreed upon?) business combination and possibly a contract with whatever company or organization hired Celestech for the optical switch. What I hope we will also hear more about is a working device or a timeline related to it's completion. It just blows my mind that they still don't have one.
Another possibility is that they may be announcing a contract with the company that hired Celestech for the optical switch so that Lightwave can gain the necessary security clearances to communicate with that company directly.
Funny, just bought a little CTIX recently as well. Am also considering selling and buying back in at a lower price given the recent run-up. Seems like a gamble worth taking given the drugs' potential!
OT - IBM entering entirely new markets?
IBM: Our new gel can kill superbugs
Researchers from computer firm IBM say they have invented a new non-toxic gel that can kill deadly drug-resistant bacteria by cutting through the sludge that shelters them and attacking the germ's cell membrane...
Read more at: http://phys.org/news/2013-01-ibm-gel-superbugs.html#jCp
http://phys.org/news/2013-01-ibm-gel-superbugs.html
Sounds like they (and their industry partner) won the DARPA award. Might be time to start picking up some shares again and holding for the long term. I would bet that their industry partner is a dialysis heayweight.
Maybe we'll find out after hours. Something is up, other than the share price!
Volume is certainly higher than usual for this time of the day...
Question about AF: Does he not believe in Bavi for just the 2nd line NSCLC trial or does he not believe in Bavi as effective for ANY trials???
TIA
Less than 2 weeks to hold a CC this month. After that, we move into the "or so" part of the time frame statement. Maybe it's just me but it feels like we always end up in the "or so" eventuality. Either way, looking forward to the next communication from the company and hoping it is soon and not "soon".
FWIW I have a thought on that. They said that while they believe they have solved the thin film issue they are still working on finding the best dye loading % so that may have something to do with it.
I sold half my shares at 2.40 for a pretty nice % gain but have been counting on a pullback to buy more shares at a lower price. Was hoping we'd see sub $2 but that may not be the case depending on when additional news is released. Hence the question on the possibility of resumed short activity tomorrow..